Angel News

Back to Homepage

27th February 2020

o2h Ventures makes an investment in Pencil Biosciences a novel gene modulation biotech

The o2h Therapeutics and AI Fund, an early stage S/EIS fund investing in biotechnology therapeutics and related AI opportunities, has invested in Pencil Biosciences, a novel gene modulation biotech company based at Alderley Park, Cheshire.

Pencil Biosciences is developing a truly innovative gene modulation technology that can have an impact across a range of applications, including new therapeutic options for patients with rare diseases.


Register / Login now to read full story

In order to read the full story we need you to be registered with us, please click the links below to login or register.

Login / Register

Add a comment:




Enter the characters in the image shown:

Back to Homepage